English
Back
Download
Log in to access Online Inquiry
Back to the Top

Lionco Pharmaceutical GroupLtd's high P/S ratio is alarming ...

Lionco Pharmaceutical GroupLtd's high P/S ratio is alarming due to its falling revenue. Unless there's a significant improvement in medium-term conditions, the current share price may not be considered fair value. The company's declining revenue and high P/S ratio could negatively impact the future share price.
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates. Read more
Translate
Report
1018 Views
Comment
Sign in to post a comment